Q: Lots happening here today. I understood from all the different sources that there was an auction and identified bidders were Blackstone, Carlisle and Apollo Global and maybe others. Blackstone and Carlisle are out for now because their bids were not competitive. There is a deadline on this auction.
Who knows what is true here but is this a real process. Wouldn't there have to be something more formal that would require a news release?
CXR having a bit of an off day today. I wonder if you think the recent strength has been based on business fundamentals or speculation of a deal?
Assuming that there is no deal to be found, I think you might still find it a worthy hold as it was recently a 5i top pick on BNN. Is that still the case? What would be the argument in favour of buying more?
If a deal were to occur, within what time frame might it be reasonable to expect?
Q: If you could please comment on this U.S. company IMS Healthcare. I would greatly appreciate it. Can you classify it as tech or healthcare and how it compares to its historical data PE/PCF/PB and any other fundamental that is important to you. Would you still prefer GUD over this stock? My worry with GUD is that they do not use their cash and investors become irritated and fickle. I can benefit from IMS as it diversifies my portfolio a little more to the US.I am thinking of a 1 to 3 year hold minimum. Thank You
Q: I currently own a small position in Cerner and was wondering what your thoughts are on this company as a 1 to 2 year hold. Are there other companies in this sector that you would recommend (U.S. or Canadian)?
Thanks
I'm interested in getting exposure to the health care sector by using an available ETF. I ran across this one (IHI) through my research and would appreciate your analysis of the ETF. I think this one focusses on medical devices. Please let me know what you think the future holds for the ETF. If you think there are other investments that would be preferable I would appreciate your suggestions.
Q: I have a small position in patient home monitoring and am currently at break even. Would you consider switching t0 cxv.convalo? Which do you see as a better hold for 1 to 2 years and why? Thank you.
Q: How do you feel about the current valuation of Biosyent? They announced yesterday that they have signed a new agreement for distribution of a cardiovascular drug that they expect will add $20M to annual revenue over time (2015 FY rev was $15.39M). Assuming they can do what they say (which they have done well at in the past) do you think the share price is reasonable? This company seems to operate with great margins and is growing with free cash flow. They have $0 in debt